Tumor Recurrence 5 Years after Treatment of Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma  Mary-Margaret Chren, Eleni Linos, Jeanette S. Torres, Sarah E. Stuart, Rupa Parvataneni, W. John Boscardin  Journal of Investigative Dermatology  Volume 133, Issue 5, Pages 1188-1196 (May 2013) DOI: 10.1038/jid.2012.403 Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 Flow diagram. Derivation of analytic cohort from consecutive patients diagnosed with nonmelanoma skin cancer (NMSC) during 1999–2000. Journal of Investigative Dermatology 2013 133, 1188-1196DOI: (10.1038/jid.2012.403) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 Cumulative incidence of recurrence at the university site, Veterans Affairs Medical Center (VA) site, and the entire sample. (a) Cumulative incidence of recurrence among 667 patients with 857 nonmelanoma skin cancers (NMSCs) at the university site. No statistically significant difference (P=0.09) detected in tumors treated with destruction, excision, or Mohs surgery. (b). Cumulative incidence of recurrence among 507 patients with 631 NMSCs at the VA site. No statistically significant difference (P=0.56) detected in tumors treated with destruction, excision, or Mohs surgery. (c) Cumulative incidence of recurrence among 1,174 patients with 1,488 NMSCs in the entire sample. No statistically significant difference (P=0.26) detected in tumors treated with destruction, excision, or Mohs surgery. Journal of Investigative Dermatology 2013 133, 1188-1196DOI: (10.1038/jid.2012.403) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions